Weize Huang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Liquid Chromatography

Transcription Factor

End Stage Renal Disease

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

The Journal of pharmacology and experimental therapeutics

University of Washington (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Washington

United States

PHD :: Pharmaceutics

Purdue University

United States

BSC :: Biochemistry

Publications

Huy X Ngo, Yue Winnie Wen, Swathi Pisupati, Weize Huang, Sandhya Mandlekar
A Comparative Clinical Pharmacology Analysis of FDA-Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology. Clinical pharmacology and therapeutics (2024)
Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini, Daniel A Pollyea, Agostino Tafuri, Joseph M Brandwein, Arnaud Pigneux, Bayard L Powell, Pierre Fenaux, Rebecca L Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion G Ott, Wan-Jen Hong, Marina Y Konopleva, Michael Andreeff
Venetoclax and idasanutlin in relapsed/refractory AML: a non-randomized, open-label phase 1b trial. Blood (2022)
Weize Huang, Lindsay C Czuba, Nina Isoherranen
Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine. The Journal of pharmacology and experimental therapeutics 373 (3) (2020)
Weize Huang, Nina Isoherranen
Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption. CPT: pharmacometrics & systems pharmacology 9 (10) (2020)